The Implementation of a Post-operative Communication App to Improve Pain Control and Opioid Use
Launched by UNIVERSITY OF MINNESOTA · Nov 3, 2023
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a new communication app called OPY, designed to help patients manage pain after surgery and reduce the risk of becoming addicted to opioids. The goal is to improve how patients communicate with their healthcare team about pain and side effects while providing helpful information on managing pain and safely using opioid medications. Participants will use the OPY app, which will be available to them starting the day they leave the hospital with a new opioid prescription. This app offers daily check-ins to gather information about their pain levels and provides tips for weaning off opioids safely.
To be eligible for this trial, participants must have undergone outpatient surgery at specific M Health Fairview locations and have an active opioid prescription. They should be between the ages of 18 and 74 and cannot have a history of chronic opioid use, which means they haven't had multiple prescriptions for opioids in the last year. The trial is currently recruiting participants, and those who join will receive support through the app to help them manage their recovery more effectively.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Surgery at The M Health Fairview Clinics and Surgery Center - Maple Grove (Maple Grove) or M Health Fairview Clinics and Surgery Center - Minneapolis (CSC)
- • ▪ Currently, only outpatient surgeries are performed at CSC and Maple Grove
- • Active opioid prescription (prescribed between 30 days prior to surgery, until day of surgery)
- • Patient class (outpatient or same day surgery)
- • Never previously randomized or exposed to OPY
- Exclusion Criteria:
- • Age \< 18
- * Chronic opiate use defined as:
- • Patients aged 18 and older and
- • 3 or more opioid dispensing events, in the last 12 months with at least 1 of these events in the last 6 months.
- • Any long acting opioid prescription in the last 6 months
- • Interpreter needed - YES selected (EPT840)
- • Patient has a Health Proxy (Legal Guardian) designated in Epic
- • Patients who have opted out of clinical research
- • Patients with an active palliative care referral
About University Of Minnesota
The University of Minnesota is a leading academic institution renowned for its commitment to advancing healthcare through innovative research and clinical trials. With a focus on interdisciplinary collaboration, the university leverages its extensive resources and expertise to conduct cutting-edge studies aimed at improving patient outcomes and addressing critical health challenges. Its robust clinical trial program emphasizes ethical standards, patient safety, and scientific rigor, contributing to the development of novel therapies and interventions that enhance medical practice and public health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Minneapolis, Minnesota, United States
Patients applied
Trial Officials
Genevieve Melton-Meaux, PhD
Principal Investigator
University of Minnesota
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported